Quick Answer
Neurogene Inc. reported Earnings Per Share Diluted of $4.24 (loss) per share for the year ending 2025.
- Neurogene Inc. showed an increase of +0.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Neurogene Inc.'s Earnings Per Share Diluted has declined by 562.5%.
- Historical annual values: Fiscal year 2025: $4.24 (loss) per share | Fiscal year 2024: $4.28 (loss) per share | Fiscal year 2023: $2.93 per share | Fiscal year 2022: $1.04 (loss) per share | Fiscal year 2021: $1.10 (loss) per share | Fiscal year 2020: $0.64 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: